Glenn Prestwich, PhD, is a presidential professor in the Department of Medicinal Chemistry at the University of Utah, a member of the Imaging, Diagnostics, and Therapeutics Program, and the Gastrointestinal Cancers Program.

Prestwich developed a new way to introduce human cancers into mice, which can be used to study how cancer will respond to chemotherapy drugs in a living animal. The goal is to create “personalized mice” in which several experimental treatments can be tested. The results of such tests can determine the best cancer treatment for patients. Prestwich also studies a series of molecules that are important in cell growth and metastasis and commonly overactive in cancers.

Prestwich received a bachelor’s degree from the California Institute of Technology, Pasadena, and a PhD from Stanford University. He was a postdoctoral fellow at Cornell University.